944401-55-2

Basic information

• Product Name: 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
• Synonyms: 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine;[4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]amine;4-Methyl-2-aminopyrimidine-5-boronic acid pinacol ester;2-PyriMidinaMine, 4-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-;2-AMino-4-MethylpyriMidine-5-boronic acid pinacol ester, 96%;4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);(2-AMINO-4-METHYLPYRIMIDIN-5-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 944401-55-2
• Molecular Formula: C₁₁H₁₈BN₃O₂
• Molecular Weight: 235
• Mol File: 944401-55-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.11
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine(944401-55-2)
• EPA Substance Registry System: 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine(944401-55-2)

Safety Data

• TSCA: N
• Hazardous Substances Data: 944401-55-2(Hazardous Substances Data)

Usage

Uses

2-Amino-4-methylpyrimidine-5-boronic acid pinacol ester is used as pharmaceutical intermediate.

Upstream product

• 17321-93-6 5-bromo-4-methylpyrimidine-2-ylamine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1033739-92-2 GNE-490 

Relevant articles and documents

MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF

Selective mTOR inhibitors of formulas (I)-(III), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from abnormal cell growth, functions, or behaviors mediated by an mTOR kinase and/or one or more PI3K enzyme, are provided. Such diseases and disorder include cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.

PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS

Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof ; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.